Post-ACL Reconstruction Rehab UPSCALER App RCT HPUPM
Primary Purpose
ACL Injury
Status
Not yet recruiting
Phase
Not Applicable
Locations
Malaysia
Study Type
Interventional
Intervention
UPSCALER app
Sponsored by
About this trial
This is an interventional treatment trial for ACL Injury
Eligibility Criteria
Inclusion criteria:
- Male and female
- Patients above the age of 18
- Patients with ACL injury who undergo ACL reconstruction surgery with or without meniscectomy
- Patients who receive autologous hamstring grafts for ACL reconstruction
- Malaysian
Exclusion criteria:
- Patients below the age of 18
- Patients unwilling to participate
- Patients with concurrent injuries to other structures in the ipsilateral knee e.g. multiligamentous injuries
- Non-Malaysian
- Patients who require meniscus repair instead of meniscectomy
Sites / Locations
- Hospital Pengajar Universiti Putra Malaysia
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Intervention
Control
Arm Description
Use of UPSCALER App
No app used. Conventional treatment.
Outcomes
Primary Outcome Measures
KOOS score
Pattient administered scoring system
Secondary Outcome Measures
Full Information
NCT ID
NCT05498285
First Posted
August 8, 2022
Last Updated
August 10, 2022
Sponsor
Hospital Pengajar Universiti Putra Malaysia
1. Study Identification
Unique Protocol Identification Number
NCT05498285
Brief Title
Post-ACL Reconstruction Rehab UPSCALER App RCT HPUPM
Official Title
A Pilot Single-blind Parallel Randomised Controlled Trial Comparing Mobile App (UPSCALER) to Standard Care in the Rehabilitation of ACL Injury After Reconstructive Surgery
Study Type
Interventional
2. Study Status
Record Verification Date
August 2022
Overall Recruitment Status
Not yet recruiting
Study Start Date
September 1, 2022 (Anticipated)
Primary Completion Date
August 31, 2023 (Anticipated)
Study Completion Date
August 31, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hospital Pengajar Universiti Putra Malaysia
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
EXECUTIVE SUMMARY
Research Title An Android Application-Based Delivery of Guided Rehabilitation After Anterior Cruciate Ligament Reconstruction: A Randomised Single-Blinded Pilot Study
Investigators Principle Investigator (Supervisor) : Prof Madya Dr Mohd Nizlan Mohd Nasir Co-investigator (Supervisor) : Dr Khairil Anwar bin Ahmad Hanif Dr Firdati binti Mohamed Saaid Co-Investigator (Student) : Dr Tan Eng Kee
Background Anterior cruciate ligament injuries are a common and significant injury seen in active persons. This injury can adversely affect the patient's daily life, as well as delay or prevent return to sports, in addition to predisposing patients to long-tern knee conditions such as osteoarthritis. Despite surgical advances, ACL reconstruction surgery outcomes are still considered poor, with a low as 55% of patients returning to active sports. One of the key factors that lead to a poorer outcome is the patient's compliance to rehabilitation, causing less than satisfactory results in the post-operative period. With the conventional regime, rehabilitation typically takes one year. Patients tend to drop out of the rehabilitation regime due to its long duration. In order to combat this, the accelerated regime was developed and only took 6 months. This regime has been researched and validated by numerous international publications since its inception. However, compliance remained poor.
Purpose of Study The study aims to assess the feasibility and effectiveness of a smartphone-based application to guide the patient's rehabilitation regime and improve compliance.
Data Gathering and Analysis Data for outcome assessment will be obtained via a patient administered questionnaire called the Knee Injury and Osteoarthritis Outcome Score (KOOS). This scoring system is available for free without licensing requirements, and has been validated by numerous research publications internationally.
Analysis of obtained data will be performed using SPSS version 22. Continuous data will be displayed as mean + SD as well as median.
Conclusion There is a need for a new method of information provision as the country moves towards the age of information technology. This smartphone-based application for guided rehabilitation will be an innovative new method to aid patients.
Lastly, the researchers would like to thank the members of JKEUPM for their time, effort and kind consideration of this research proposal.
Detailed Description
Study Design:
Single-blinded randomized control pilot study
Study Location:
Hospital Pengajar Universiti Putra Malaysia Orthopaedic Department
Study Duration:
1 year (September 2022 to August 2023)
Study Population:
Consenting patients from HPUPM Orthopaedic Department, SIASCOE Unit who are undergo elective arthroscopic ACL reconstruction surgery
Sample Size:
The sample size for this study was concluded to be 30 based on the objectives. Different sample sizes were calculated and the highest number was taken. (See Appendix A)
Patient Recruitment:
Patients from the SIASCOE clinic who fall within the inclusion criteria will be informed regarding this research using the patient's information sheet. Should they choose to join the research; consent will be obtained with a witness present.
They will also be informed as any patient would, that the surgery will be performed by the same team using the anatomical ACL reconstruction technique. Concomitant procedures such as meniscectomy or meniscal repair, operative time as well as tourniquet time and pressure will be recorded as with any other patient who undergoes an ACL reconstruction. Post-operative precautions will be taken as with any patient. A hinge knee brace and a compressive wrap will be used immediately post-op, cryocuff therapy started once patient is back in the ward.
Patient Randomization Patients will be randomized into treatment or control arm based on the last digit of their UPM registration number. Even numbers for treatment, and odd numbers for control.Patient forms will be colour coded to either red or blue for blinding of the researcher. Patients in the control arm will not be informed of the usage of the app as it may create a bias.
Data Collection and Researcher Blinding KOOS forms will be provided to the participant. They will be placed in a private setting during the self-administered assessment with an investigator available for any queries. Privacy and confidentiality will be ensured and there will be no personal data included in the KOOS forms. All participants will be assigned an identification number known only to the primary researcher and all KOOS forms will be colour coded to indicate the randomly assigned group of the participant.
SIRAS assessment forms will also be provided to patients during follow up to assess adherence to the rehabilitation regime. This assessment form will be filled by the physician and consist of three items that assess the patient's intensity during rehabilitation, ability to follow instructions, and their receptiveness to the rehabilitation.
Two researchers will be allocated for data collection. Researcher A will obtain data related to KOOS and SIRAS scoring. This researcher will be blinded and provided with colour coded forms according to the group that the patient has been randomized to.
Researcher B will obtain data related to acceptance of the mobile app. This researcher is unable to be blinded and will only be allocated to patients in the treatment group.
The data collected by this Researcher B will be stored in a separate location from the data collected by Researcher A until the study is completed. They will only be compiled immediately prior to data analysis.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
ACL Injury
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
30 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Intervention
Arm Type
Experimental
Arm Description
Use of UPSCALER App
Arm Title
Control
Arm Type
No Intervention
Arm Description
No app used. Conventional treatment.
Intervention Type
Behavioral
Intervention Name(s)
UPSCALER app
Intervention Description
Usage of mobile app to guide rehabilitation after surgery
Primary Outcome Measure Information:
Title
KOOS score
Description
Pattient administered scoring system
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria:
Male and female
Patients above the age of 18
Patients with ACL injury who undergo ACL reconstruction surgery with or without meniscectomy
Patients who receive autologous hamstring grafts for ACL reconstruction
Malaysian
Exclusion criteria:
Patients below the age of 18
Patients unwilling to participate
Patients with concurrent injuries to other structures in the ipsilateral knee e.g. multiligamentous injuries
Non-Malaysian
Patients who require meniscus repair instead of meniscectomy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Eng Kee Tan, MBBS
Phone
+60124707771
Email
ektan86@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Mohd Nizlan Mohd Nasir, MS Ortho
Phone
+60397695567
Email
ektan86@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Eng Kee Tan, MBBS
Organizational Affiliation
Hospital Pengajar Universiti Putra Malaysia
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Pengajar Universiti Putra Malaysia
City
Serdang
State/Province
Selangor
ZIP/Postal Code
42400
Country
Malaysia
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Post-ACL Reconstruction Rehab UPSCALER App RCT HPUPM
We'll reach out to this number within 24 hrs